L Sangaré1, S Diandé, G Badoum, B Dingtoumda, A S Traoré. 1. Service de Bactériologie-Virologie, Centre Hospitalière Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso. sangarel@hotmail.com
Abstract
SETTING: National Tuberculosis (TB) Control Centre in Ouagadougou, Burkina Faso. OBJECTIVE: To evaluate Mycobacterium tuberculosis drug resistance among newly diagnosed and previously treated cases. METHODS: A total of 416 M. tuberculosis complex strains were isolated from 323 new and 93 previously treated patients under DOTS. Susceptibility to four anti-tuberculosis drugs (isoniazid [INH], rifampicin [RMP], streptomycin [SM] and ethambutol [EMB]) was determined using the proportion method. Human immunodeficiency virus (HIV) status was determined in 316 patients, 249 new and 67 previously treated cases, with informed consent. RESULTS: Among new cases, 12.4% of strains were resistant to any drug, and 3.4% were multidrug-resistant (MDR). Resistance rates were very high in previously treated patients: INH (66.7%), RMP (51.6%), SM (44.1%), EMB (50.5%) and MDR (INH+RMP; 50.5%). Of 316 patients tested, 28.7% were HIV-positive. There was no statistically significant association between HIV status and MDR-TB in new (P = 0.95) and previously treated patients (P = 0.5). CONCLUSION: Drug resistance is high in Burkina Faso. Early detection of infectious patients and completion of treatment are essential.
SETTING: National Tuberculosis (TB) Control Centre in Ouagadougou, Burkina Faso. OBJECTIVE: To evaluate Mycobacterium tuberculosis drug resistance among newly diagnosed and previously treated cases. METHODS: A total of 416 M. tuberculosis complex strains were isolated from 323 new and 93 previously treated patients under DOTS. Susceptibility to four anti-tuberculosis drugs (isoniazid [INH], rifampicin [RMP], streptomycin [SM] and ethambutol [EMB]) was determined using the proportion method. Human immunodeficiency virus (HIV) status was determined in 316 patients, 249 new and 67 previously treated cases, with informed consent. RESULTS: Among new cases, 12.4% of strains were resistant to any drug, and 3.4% were multidrug-resistant (MDR). Resistance rates were very high in previously treated patients: INH (66.7%), RMP (51.6%), SM (44.1%), EMB (50.5%) and MDR (INH+RMP; 50.5%). Of 316 patients tested, 28.7% were HIV-positive. There was no statistically significant association between HIV status and MDR-TB in new (P = 0.95) and previously treated patients (P = 0.5). CONCLUSION: Drug resistance is high in Burkina Faso. Early detection of infectious patients and completion of treatment are essential.
Authors: Deus Lukoye; Willy Ssengooba; Kenneth Musisi; George W Kasule; Frank G J Cobelens; Moses Joloba; Gabriela B Gomez Journal: BMC Public Health Date: 2015-03-25 Impact factor: 3.295
Authors: Sydney Malama; Tone Bjordal Johansen; John Bwalya Muma; Musso Munyeme; Grace Mbulo; Adrian Muwonge; Berit Djønne; Jacques Godfroid Journal: Vet Med Int Date: 2014-04-14
Authors: Florian Gehre; Jacob Otu; Lindsay Kendall; Audrey Forson; Awewura Kwara; Samuel Kudzawu; Aderemi O Kehinde; Oludele Adebiyi; Kayode Salako; Ignatius Baldeh; Aisha Jallow; Mamadou Jallow; Anoumou Dagnra; Kodjo Dissé; Essosimna A Kadanga; Emmanuel Oni Idigbe; Catherine Onubogu; Nneka Onyejepu; Aissatou Gaye-Diallo; Awa Ba-Diallo; Paulo Rabna; Morto Mane; Moumine Sanogo; Bassirou Diarra; Zingue Dezemon; Adama Sanou; Madikay Senghore; Brenda A Kwambana-Adams; Edward Demba; Tutty Faal-Jawara; Samrat Kumar; Leopold D Tientcheu; Adama Jallow; Samba Ceesay; Ifedayo Adetifa; Assan Jaye; Mark J Pallen; Umberto D'Alessandro; Beate Kampmann; Richard A Adegbola; Souleymane Mboup; Tumani Corrah; Bouke C de Jong; Martin Antonio Journal: BMC Med Date: 2016-11-03 Impact factor: 8.775
Authors: Lovett Lawson; Nanmdi Emenyonu; Saddiq T Abdurrahman; Juliana O Lawson; Gertrude N Uzoewulu; Olumide M Sogaolu; Juliana N Ebisike; Christopher M Parry; Mohammed A Yassin; Luis E Cuevas Journal: BMC Res Notes Date: 2013-05-30